CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
HiResolution Bionic Cochlear Implantdevice
Likely dose
HiResolution Bionic Ear (HiRes 90K Advantage with HiFocus 1J, HiFocus Helix, or HiFocus Mid-Scala electrode, or HiRes Ultra with HiFocus Mid-Scala electrode) implanted in one earAI-extracted
Key inclusion· 8
  • Age 18 years or older
  • Able to provide informed consent and proficient in English
  • Willingness to participate in all scheduled procedures and use approved cochlear implant processing strategy
  • Ear to be implanted: Severe-to-profound sensorineural hearing loss >70 dB HL (pure tone average at 500, 1000, 2000, 4000 Hz)
Key exclusion· 7
  • Previous cochlear implant experience in either ear
  • Cochlear malformation or obstruction (ossification) that would prevent full electrode array insertion in implant ear
  • Medical or psychological conditions that contraindicate surgery or impair ability to manage implant device or comply with study procedures
  • Diagnosis of auditory neuropathy/dys-synchrony in either ear

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02811549
NCT02811549N/ACompleted

Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss

Advanced Bionics·interventional·Posted Jun 23, 2016·Updated Aug 21, 2023

In Brief

A clinical study evaluating HiResolution Bionic Cochlear Implant for Hearing Loss and 5 related conditions. Completed, enrolled 24 participants across 2 sites.

Detailed Summary

The purpose of this feasibility study is to evaluate the benefit of unilateral implantation in adults who have severe to profound sensorineural hearing loss in one ear, and up to moderate sensorineural hearing loss in the other ear (asymmetric hearing loss).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 23, 2016
Enrollment StartNov 7, 2016
Primary CompletionMar 25, 2020
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 10.0 years ago

Interventions

HiResolution Bionic Cochlear Implantdevice

HiRes 90K™ Advantage implant with HiFocus™ 1J electrode, HiRes 90K™ Advantage implant with the HiFocus Helix™ electrode, HiRes 90K™ Advantage implant with the HiFocus™ Mid-Scala electrode or the HiRes™ Ultra Implant with the HiFocus™ Mid-Scala electrode will be implanted in adults with eligible hearing profile.